Local Administration of a Thermoresponsive Hydromorphone Prodrug Provides Sustained Analgesia in a Rodent Fracture Model with Reduced Systemic Opioid Effects

Opioids are potent analgesic agents, frequently being used to manage severe pain associated with musculoskeletal (MSK) trauma. The adverse effects of systemic opioids, such as respiratory depression, development of dependency and tolerance have impeded clinical opioid utility. To overcome these limitations, we have developed N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer-based thermoresponsive polymeric prodrugs (ProGel-HMP) of hydromorphone (HMP) as a novel peripherally restricted analgesic agent for local management of MSK pain. In the present study, ProGel-HMP formulations were synthesized and characterized for their physicochemical properties. The localized retention and tissue biodistribution were assessed using near-infrared (NIR) optical imaging in a mouse model of closed femoral fracture. Analgesic efficacy was evaluated through static weight-bearing (incapacitance test) and dynamic gait analysis (CatWalk XT) over three weeks post-ProGel-HMP administration. Potential systemic analgesia was assessed via tail-flick latency. The risk of respiratory depression was evaluated using whole-body plethysmography in rats. Quantitative micro-computed tomography (micro-CT) was performed at 6 weeks post-ProGel-HMP treatment to screen for any potential impacts on the fracture healing process. NIR optical imaging confirmed that local intra-callus injection of ProGel-HMP resulted in its sustained retention at the fracture site for at least 14 days. A single local administration of ProGel-HMP provided sustained pain relief, maintaining balanced static weight distribution and improved dynamic gait parameters for up to 21 days post-fracture, whereas dose-equivalent free HMP lost efficacy within 2 days. Tail-flick testing demonstrated substantially reduced systemic antinociceptive activity following ProGel-HMP administration compared with dose-equivalent free HMP. Whole body plethysmography revealed no significant impairment in respiratory rate, tidal volume, or minute ventilation. Quantitative micro-CT analysis verified that ProGel-HMP treatment did not compromise the fracture healing process, with similar callus morphology, bone mineral density, and microstructural parameters when compared to controls. In conclusion, intra-callus administration of thermoresponsive ProGel-HMP provides potent and sustained local analgesia in a closed femoral fracture mouse model. These findings support ProGel-HMP’s potential as a promising peripherally restricted analgesia for pain management in orthopaedic trauma.

Authors

Institutions

Publication Details

Journal
Gels
Published
2026-11-13
DOI
https://doi.org/10.3390/gels12111041
Primary Topic
Pain Management and Opioid Use
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Local Administration of a Thermoresponsive Hydromorphone Prodrug Provides Sustained Analgesia in a Rodent Fracture Model with Reduced Systemic Opioid Effects

Michael Lush, Jie Rong, Yangwei Deng, Shabnam Arash et al.
1 links
Gels
Pain Management and Opioid Use
article

Local Administration of a Thermoresponsive Hydromorphone Prodrug Provides Sustained Analgesia in a Rodent Fracture Model with Reduced Systemic Opioid Effects

Michael Lush, Jie Rong, Yangwei Deng, Shabnam Arash, Shahnaz Rahimi, Edward V. Fehringer, Hanjun Wang, Dong Wang, Eleanor Clare Ransdell-Green, Xiaoqing Du, Mengmeng Liu, Detrek Y. Hansen, Xin Fu, Artem Marchenko
article en

Abstract

Opioids are potent analgesic agents, frequently being used to manage severe pain associated with musculoskeletal (MSK) trauma. The adverse effects of systemic opioids, such as respiratory depression, development of dependency and tolerance have impeded clinical opioid utility. To overcome these limitations, we have developed N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer-based thermoresponsive polymeric prodrugs (ProGel-HMP) of hydromorphone (HMP) as a novel peripherally restricted analgesic agent for local management of MSK pain. In the present study, ProGel-HMP formulations were synthesized and characterized for their physicochemical properties. The localized retention and tissue biodistribution were assessed using near-infrared (NIR) optical imaging in a mouse model of closed femoral fracture. Analgesic efficacy was evaluated through static weight-bearing (incapacitance test) and dynamic gait analysis (CatWalk XT) over three weeks post-ProGel-HMP administration. Potential systemic analgesia was assessed via tail-flick latency. The risk of respiratory depression was evaluated using whole-body plethysmography in rats. Quantitative micro-computed tomography (micro-CT) was performed at 6 weeks post-ProGel-HMP treatment to screen for any potential impacts on the fracture healing process. NIR optical imaging confirmed that local intra-callus injection of ProGel-HMP resulted in its sustained retention at the fracture site for at least 14 days. A single local administration of ProGel-HMP provided sustained pain relief, maintaining balanced static weight distribution and improved dynamic gait parameters for up to 21 days post-fracture, whereas dose-equivalent free HMP lost efficacy within 2 days. Tail-flick testing demonstrated substantially reduced systemic antinociceptive activity following ProGel-HMP administration compared with dose-equivalent free HMP. Whole body plethysmography revealed no significant impairment in respiratory rate, tidal volume, or minute ventilation. Quantitative micro-CT analysis verified that ProGel-HMP treatment did not compromise the fracture healing process, with similar callus morphology, bone mineral density, and microstructural parameters when compared to controls. In conclusion, intra-callus administration of thermoresponsive ProGel-HMP provides potent and sustained local analgesia in a closed femoral fracture mouse model. These findings support ProGel-HMP’s potential as a promising peripherally restricted analgesia for pain management in orthopaedic trauma.

GelsVol. 12(11)
University of Nebraska Medical Center (US)
Good health and well-being
Pain Management and Opioid Use
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon